Drug intelligence / Profile preview

house dust extract

Development stage: Preclinical
Lead developer: ALK Abelló
Modality: Small Molecules
Administration: Subcutaneous

Overview

House dust extract is a biological preparation derived from house dust, containing various allergens. It is primarily used in immunotherapy for allergic conditions such as asthma and allergic rhinitis, aiming to desensitize patients to these allergens. It has been studied in controlled trials for its efficacy, with administration typically involving injections.

Beyond the preview

Go deeper on house dust extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on house dust extract.

Explore the full profile